Category: Publications

Researchers at Northwestern and the University of Illinois at Chicago have engineered an artificial ribosome, which may enable the production of new drugs and next-generation biomaterials.

Synthetic biologist Joshua Leonard and his team have developed a technology for engineering human cells as therapies that become activated only in diseased tissues.

Northwestern synthetic biology researchers, working with partners at Harvard Medical School, have for the first time synthesized protein-generating cell structures called ribosomes in a test tube.